The Food and Drug Administration's (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respiratory viral season. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) for the FDA will meet Thursday to discuss whether COVID-19 vaccines should target the...
The Food and Drug Administration's (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respiratory viral season. The Vaccines and Related Biological Products Advisory Committee (VRBPAC) for the FDA will meet Thursday to discuss whether COVID-19 vaccines should target the...
<iframe src="https://statesidedaily.com/embed/cluster/b6e03a4784049af9a4c5e19a2d21350c25b09a6a" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="FDA advisers to weigh updated COVID vaccine targeting XFG subvariant"></iframe>
